Cargando…

33892 Telehealth use at a specialty hidradenitis suppurativa clinic during the COVID-19 pandemic

Detalles Bibliográficos
Autores principales:	Kim, Diana S., Kimball, Alexa B., Porter, Martina L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465234/ http://dx.doi.org/10.1016/j.jaad.2022.06.494

Ejemplares similares

TNF-α inhibitors in the treatment of hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2019)

Response to: Remission of hidradenitis suppurativa after bariatric surgery
por: Golbari, Nicole Mona, et al.
Publicado: (2018)

Travel burden on patients at a subspecialty hidradenitis suppurativa clinic: a single-center retrospective study
por: Kim, Diana S., et al.
Publicado: (2022)

Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities
por: Morss-Walton, Peyton C., et al.
Publicado: (2022)

Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa
por: Gibson, Ruby S., et al.
Publicado: (2022)

Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients
por: Savage, Kevin T., et al.
Publicado: (2020)

A practical guide to starting a hidradenitis suppurativa specialty clinic
por: Shih, Terri, et al.
Publicado: (2023)

Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2020)

Reply to “A practical guide to starting a hidradenitis suppurativa specialty clinic”
por: Park, Helen H., et al.
Publicado: (2023)

Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations
por: Garg, Amit, et al.
Publicado: (2022)

Impact of the COVID‐19 pandemic on patients with hidradenitis suppurativa
por: Fiocco, Zeno, et al.
Publicado: (2022)

Surgical management of hidradenitis suppurativa
por: Gierek, Marcin, et al.
Publicado: (2022)

Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic
por: Kearns, Donovan G., et al.
Publicado: (2020)

Hidradenitis suppurativa: The importance of virtual outpatient care during COVID-19 pandemic
por: Shah, Monica, et al.
Publicado: (2020)

Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations
por: Blaszczak, Alecia, et al.
Publicado: (2020)

Hidradenitis suppurativa in AIDS
por: Khambhati, Ravi, et al.
Publicado: (2010)

Hidradenitis suppurativa and intimacy
por: Jemec, G.
Publicado: (2018)

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa?
por: Fletcher, Joshua, et al.
Publicado: (2021)

Experience in patients with hidradenitis suppurativa and COVID-19 symptoms
por: Galán, José Luis, et al.
Publicado: (2020)

Clinical Epidemiology and Management of Hidradenitis Suppurativa
por: Sayed, Christopher J., et al.
Publicado: (2021)

Hidradenitis suppurativa and adalimumab in the COVID-19 era
por: Marzano, Angelo Valerio, et al.
Publicado: (2021)

Obstacles to Early Diagnosis and Treatment of Hidradenitis Suppurativa: Current Perspectives on Improving Clinical Management
por: Snyder, Corey L, et al.
Publicado: (2023)

The role of virtual support groups for patients with hidradenitis suppurativa during the COVID-19 pandemic
por: Stout, Molly
Publicado: (2020)

The Impact of Telemedicine on Patients with Hidradenitis Suppurativa in the COVID-19 Era
por: Gierek, Marcin, et al.
Publicado: (2023)

Hidradenitis suppurativa in patients with and without erythrasma
por: Del Ángel Hernández, Mariela, et al.
Publicado: (2023)

Surgical Management of Hidradenitis Suppurativa
por: Menderes, Adnan, et al.
Publicado: (2010)

Hidradenitis Suppurativa: Inside and Out
por: Patil, Sharmila, et al.
Publicado: (2018)

Multimodal management of hidradenitis suppurativa
por: Jemec, Gregor B.E.
Publicado: (2020)

Leflunomide-Induced Hidradenitis Suppurativa
por: Machan, Achraf, et al.
Publicado: (2020)

Secondary prevention of hidradenitis suppurativa
por: Kurzen, Hjalmar, et al.
Publicado: (2019)

Facklamia hominis in hidradenitis suppurativa
por: Basal, Yasmeen, et al.
Publicado: (2021)

Management of Severe Hidradenitis Suppurativa
por: Katzman, Ju Hee, et al.
Publicado: (2021)

Vulvar cancer in hidradenitis suppurativa
por: Vergeldt, T.F.M., et al.
Publicado: (2022)

Surgical Treatment in Hidradenitis Suppurativa
por: Shukla, Ratnakar, et al.
Publicado: (2022)

Hydroxychloroquine for the treatment of hidradenitis suppurativa
por: Brant, Elena Gonzalez, et al.
Publicado: (2023)

Certolizumab to treat hidradenitis suppurativa
por: Shadid, Asem, et al.
Publicado: (2022)

Dietary Factors and Hidradenitis Suppurativa
por: Shen, Alan S., et al.
Publicado: (2023)

Primary alterations during the development of hidradenitis suppurativa
por: Dajnoki, Z., et al.
Publicado: (2021)

Postoperative Quality of Life in Patients with Hidradenitis Suppurativa Utilizing the Hidradenitis Suppurativa Burden of Disease Tool
por: Guart, Jiddu A, et al.
Publicado: (2021)

Hidradenitis suppurativa: bacteriological study in surgical treatment
por: Gierek, Marcin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cpj8bc7refhhq1g5cemn042tf8